While there is
not the same level of surface area as the all-metal implants, the corrosion
which can occur in the Stryker Rejuvenate and Stryker ABGII can nonetheless
lead to metallosis. In addition to the neck juncture which can result in corrosion,
there are metal trunnions located at either end of the neck which allow the
component to snap into the stem on one end and the acetabular
cup on the other. Body fluids can become trapped under these trunnions, leading
to further corrosion.
Showing posts with label Stryker lawsuit. Show all posts
Showing posts with label Stryker lawsuit. Show all posts
Tuesday, January 15, 2013
The Stryker Orthopedics PER Letter: Why All Rejuvenate and ABGII Hip Implant Recipients Should be Cautious
Wednesday, November 21, 2012
Why Diagnosing Problems in Stryker Rejuvenate Hip Implants is So Difficult
When the Stryker Rejuvenate and ABGII were recalled in July of 2012,
citing potential risk of fretting and corrosion at the neck juncture, many of
the implants had already been removed during revision surgeries. Unfortunately,
since most physicians were unaware of the problems with the implants, the
operative reports were unlikely to list this corrosion. In other words, since
the doctors hadn’t been told what issues to look for, there were few records
stating that corrosion was a factor in the revision surgery. When Stryker
originally told hospitals and surgeons (in an Urgent Field Safety Report in
April of 2012) that there could be corrosion or fretting and release of metal
ions, there was still no mention of that corrosion occurring anywhere except at
the neck juncture.
Tuesday, November 20, 2012
Sales Dip for Stryker Following Hip Implant Recalls
Stryker sales have shown a definite dip in the quart since the recall of
the Stryker Rejuvenate and ABGII hip implants in July. The hip implant recall
came just months after Stryker issued an Urgent Field Safety Notice to
hospitals and physicians in April of 2012 citing the potential of fretting and
corrosion at the neck juncture as well as the risk of metal ion release.
Stryker’s hip implant sales dropped nearly 10 percent while its knee implant
sales dropped 4.3 percent.
Why the Dip in Revenues?
A Stryker company official stated the recalls of the Rejuvenate and ABGII
had only a “modest impact” on the company’s third quarter drop in sales. While
the recalls certainly would have impacted Stryker’s revenues, the overall
economy may also have played a part. Joint replacement surgical procedures are
considered elective most of the time. Those with insurance may delay the
surgery to avoid missing work while those without insurance likely cannot
afford the procedure. Stryker’s CFO, Curt Hartman also stepped down after two
decades at the helm. He reportedly received a 1.5 million dollar separation
package although he will remain as an adviser to Stryker through February,
2013.
New Design an Improvement Over Metal-on-Metal
Implants?
Metal-on-metal hip implants have been responsible for scores of side
effects among recipients. The Rejuvenate garnered FDA approval in 2008 and the
ABGII in 2009 and were believed to be not only safer than the all-metal
implants but the design was innovative in that the stem and neck were separate
parts and were manufactured in a variety of sizes. The surgeon could choose the
best size according to the size and activity level of the patient. Because the
ball of the Stryker models was ceramic and plastic lined the acetabular cup, it
was assumed there would be no metal-on-metal parts rubbing against one another,
resulting in metal ions shearing away into the body.
Risk of Metal Ion Release
Unfortunately, the neck portion of the Stryker Rejuvenate is made of
cobalt and chromium and even though the ball is ceramic, there is a metal
intersection as well as metal trundles at both ends of the neck portion. Body
fluids trapped in the trundles can lead to corrosion and the metal intersections
can also corrode, sending metal ions into the surrounding tissues or the
bloodstream. Although the levels of metal ions in the bloodstream from the
Rejuvenate may not reach the level of the all-metal implants, any metal in the
body can cause issues for the patient. Those patients who are extremely active
have an even greater risk of metallosis, leading to pain, necrosis, infection
and failure of the implant. While Stryker’s sales may have taken a dip, it is
likely that they will soon have bigger problems as eight lawsuits have already
been filed following the Rejuvenate and ABGII hip implant recalls.
Monday, November 19, 2012
Consolidation of Stryker Rejuvenate Hip Lawsuits Placed in New Jersey
The state of New Jersey is expected to consolidate at least ten StrykerRejuvenate and ABGII hip implant lawsuits before one judge in order to expedite
the handling of these cases. Multi-district and multi-county litigation is
described by Class Action Litigation website as a procedure utilized by federal
and state courts to transfer all pending cases which are very similar in nature
before one judge. This procedure allows lawsuits to move in a more expeditious
manner through the discovery phase while still allowing the injured party to
seek an individual trial and have their settlement adjusted based on the degree
of injury. This is unlike class action lawsuits which dictate that all members
share equally in the settlement even though it is unlikely that all injuries
would be equal. The first ten cases are coming from Florida, Minnesota, New
Jersey and Arizona. Hackensack, NJ was chosen as the consolidation point
because it is close to Stryker headquarters.
Wednesday, October 17, 2012
Preserving Your Right to a Stryker Hip Implant Lawsuit
If you or
a loved one is the recipient of a Stryker ABGII or Stryker Rejuvenate hip
implant device it is very important that you preserve your health, your future
and your right to recovery. Between the time the devices received approval and
hit the market (June 2008 and November, 2009) Stryker received reports of
health and safety risks regarding the Rejuvenate and the ABGII. Surgeons across
the United States submitted reports which voiced concern for the amount of
corrosion and fretting seen in the devices which had been removed from their
patients, with one surgeon stating it looked like “black rust” around the
modular neck junction.
The April 2012 Urgent Safety
Bulletin
In a
safety bulletin sent to surgeons and hospitals in April of 2012, Stryker noted
that excessive metal debris and ion generation were commonly seen in these
Stryker hip implant models. Further, high levels of corrosion and fretting were
resulting from the metal ion generation, leading to early failure of the device
and the necessity of revision surgery. In this safety bulletin Stryker noted
that a certain ph level in some patients caused them to be at a greater risk of
harm. Further, they stated that tapers which were not adequately locked or
sufficiently cleaned could lead to an increase in metal debris generation.
How the Rejuvenate and ABGII
Gained FDA Approval
Both the
Stryker Rejuvenate and the ABGII received FDA approval through a process known
as the 510(k). This process allows medical devices and drugs to skip clinical
trials by asserting they are substantially similar to a device or drug which
has already been approved. Of course the drug or device they are claiming to be
similar to could have gained approval in the same way. In this particular case,
the Wright Profemur was the device the Rejuvenate claimed to be substantially
similar to, and the Profemur has had its share of adverse events among its
recipients as well. This process causes unsuspecting patients to become guinea
pigs as the manufacturer really has no idea whether or not the device or drug
is truly safe. Most of us expect that our surgeons will not implant an unsafe
device into our bodies, and most surgeons expect that an FDA approved device or
drug can be considered safe. Unfortunately this is not always the case, and the
metal-on-metal hip implants have had more than their share of troubles.
Don’t Lose Your Right to File
a Claim against Stryker
It is
believed that over half a million Americans currently have a metal-on-metal hip
implant in their body which is, in some ways, akin to a ticking time bomb. When
the metal ions shear away from the device they become lodged in the surrounding
tissue and cause pain and inflammation or they make their way to the bloodstream
where they can eventually cause metal toxicity. The symptoms of metal toxicity
may lay dormant for as long as several years and if the patient has not
preserved his or her right to recovery—by speaking to an experienced Stryker
hip recall attorney—they could find themselves with damaged health and a
mountain of medical bills following revision surgery.
Monday, October 15, 2012
Safety Warnings Regarding Stryker Rejuvenate and ABGII
Just
this last April Stryker Orthopedics issued a safety bulletin to doctors and
hospitals regarding two hip implants, the Rejuvenate and the ABGII. The
bulletin listed the potential for excessive metal debris and metal ion
generation in these hip implants, stating this could lead to extreme levels of
fretting and corrosion of the hip implant. When fretting and corrosion occur in
hip implants, the patient will usually have to undergo revision surgery which
is both risky and complex. Additionally, when the metal ions which have been
generated from the hip implant shear away from the device, they may either
become lodged in the surrounding tissues or can enter the bloodstream. Either
of these can cause serious health issues for the implant recipient.
Other Issues Related to the Safety
Bulletin
Further,
patients who have a heightened sensitivity to these metal ions could have an
allergic reaction which causes the tissue surrounding the hip to become inflamed
and painful. Stryker listed certain factors which could increase the risk of
the metal ions including femoral offset, ph factors of the individual, excess weight
of the implant recipient and patient diabetes or infection. When the femoral
has too much offset, there will be greater bending motions at the taper
junction as well as between the neck and stem.
Saturday, October 13, 2012
Is Your Safety Being Ignored in the Approval of Medical Devices and Drugs?
Adverse Health Effects from Metal
Toxicity
Any
time two metal surfaces come into contact with one another, corrosion can occur
in the form of tiny metal shards shearing away from the implant and lodging in
nearby hip tissue or entering into the bloodstream. Extreme inflammation,
chronic and severe pain and destruction or death of the tissue can result from
those tiny metal ions. Should the metal shards enter into the bloodstream,
metal toxicity can occur. Every person will respond differently to varying
levels of toxic metals in the body—while some people may have serious adverse
reactions to relatively small amounts of metals in the body, others may not
have any overt reactions until the levels are extremely high.
Monday, October 8, 2012
Stryker Rejuvenate and ABGII—Getting the Legal Help You Need
A
short time after the FDA approved the Stryker Rejuvenate metal hip implant in
June of 2008, adverse reports from recipients of the implant began coming in.
The implant remained on the market, and in November of 2009 the FDA approved
another Stryker metal hip implant, the ABGII. Both models of the metal hip
implants came in under the FDA 510(k) approval process which allows medical
devices and drugs to gain approval if the manufacturer can prove they are
substantially similar to a device or drug which has already garnered FDA
approval. While in theory this process sounds reasonable, in practice, many of
these drugs and devices were able to be approved based on prior devices or
drugs which also had their own problems.
Problems with the 510(k) Process
In
the case of the Stryker Rejuvenate, it gained FDA approval based on being
substantially similar to the Wright Profemur—which has made the news because of
harm to its recipients. In some cases one defective medical device or drug
after another can find their way onto the market—and into the bodies of
unsuspecting people who likely believe there doctor would not be able to
implant a device into their body unless it were safe. Over 500,000 people in the
United States alone have metal hip implants in their body despite the fact that
a recent FDA panel met to discuss the merits of the metal-on-metal implant and
stated that given the many problems which have surfaced on particular metal
implants, there was really no reason for surgeons to continue to implant the
metal devices.
Subscribe to:
Posts (Atom)